Medochemie Ltd.

Medochemie Ltd. is a Cyprus based pharmaceutical company selling in more than 100 countries worldwide.

Medochemie Ltd. specializes in the development, manufacture, distribution and sale of branded generic and added-value generic finished dosage forms.

With currently 4,355 marketing authorizations for 630 different pharmaceutical products, classified in over 10 therapeutic categories, Medochemie sells pharmaceutical products in 107 countries worldwide directly or via authorized distributors and to contract manufacturing and in-licensing partners. Medochemie follows rigorous quality standards in accordance with cGMP as per EU and WHO regulations.

Medochemie’s product manufacturing lines include:

• 9 facilities in Cyprus specialised in tablets, capsules, ampoules, oral and injectable penicillins, oral and injectable cephalosporins, syrups/DPFOS and dry powder inhalers (DPI)
• 1 facility in the Netherlands specialised in tablets and controlled substances;
• 3 new facilities in Vietnam specialized in oral solid dosage forms (non-betalactams), cephalosporin injectables, oral liquids and liquid suspensions, as well as creams and gels.